# Zilver® PTX® in China

Study · id `cardio:ct-nct02171962` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02171962](<https://clinicaltrials.gov/study/NCT02171962>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02171962

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT02171962. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT02171962, source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02171962, source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02171962, source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)
- Completion: 2017-02-09 (actual) (ClinicalTrials.gov record NCT02171962, source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02171962, source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02171962-2017-03-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Zilver® PTX® in China
- Condition: Peripheral Artery Disease
- Intervention (Device): Zilver® PTX® Drug-Eluting Peripheral Stent
- Lead sponsor: Cook Group Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cook Group Incorporated (`cardio:org-cook-group-incorporated`)

## Provenance

Content hash: d75f0336ad645f3cc495d55c6cedb719e520c282643d696bfd9928d9eb204806
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
